Literature DB >> 12011006

LACK-specific CD4(+) T cells that induce gamma interferon production in patients with localized cutaneous leishmaniasis during an early stage of infection.

Eliane Bourreau1, Ghislaine Prévot, Jacques Gardon, Roger Pradinaud, Hitoshi Hasagewa, Geneviève Milon, Pascal Launois.   

Abstract

The profile of cytokines induced by soluble leishmania antigen (SLA) and the Leishmania homologue of the mammalian receptor for activated C kinase (LACK), a candidate vaccine against leishmaniasis, and the cellular source of the cytokines produced in response to these antigens were analyzed in patients infected with Leishmania guyanensis. Gamma interferon (IFN-gamma) and interleukin-10 (IL-10) were produced in response to LACK. Although LACK-specific CD4(+) cells producing IFN-gamma were isolated only during the early phase of infection (less than 30 days following the onset of infection), cells producing IL-10 in response to LACK were detected in all patients. CD4(+) T cells producing IFN-gamma and IL-13 were produced in response to SLA in all patients. SLA- and LACK-specific T cells are effector memory cells, as they are CD45RA(-) CCR7(-) CD4(+) T cells. CD4(+) T cells producing IFN-gamma are CD62L(-), and CD4(+) T cells producing IL-10 are CD62L(+), indicating that these cells have different tissue-homing capacities. These findings show that SLA and LACK induce both type 1 (IFN-gamma) and type 2 (IL-10 or IL-13) cell responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011006      PMCID: PMC128026          DOI: 10.1128/IAI.70.6.3122-3129.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

2.  Interleukin (IL)-13 is the predominant Th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12.

Authors:  E Bourreau; G Prévot; R Pradinaud; P Launois
Journal:  J Infect Dis       Date:  2001-02-09       Impact factor: 5.226

3.  IFN-gamma-producing CD45RA+CD8+ and IL-10-producing CD45RA-CD4+ T cells generated in response to LACK in naive subjects never exposed to Leishmania.

Authors:  Eliane Bourreau; Marion Collet; Ghislaine Prévot; Geneviève Milon; Dominique Ashimoff; Hitoshi Hasagewa; Carlos Parra-Lopez; Pascal Launois
Journal:  Eur J Immunol       Date:  2002-02       Impact factor: 5.532

4.  Unresponsiveness of specific T cells to IL-12 is associated with active cutaneous leishmaniasis owing to Leishmania guyanensis.

Authors:  E Bourreau; G Prévot; R Pradinaud; P Launois
Journal:  Scand J Immunol       Date:  2001-09       Impact factor: 3.487

5.  Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.

Authors:  R L Bottrel; W O Dutra; F A Martins; B Gontijo; E Carvalho; M Barral-Netto; A Barral; R P Almeida; W Mayrink; R Locksley; K J Gollob
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  Induction and abrogation of LACK reactive cells in the evolution of human leishmaniasis.

Authors:  K Maasho; D Wolday; M Edjigu; K Söderström; S Britton; H Akuffo
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

7.  A Leishmania homologue of receptors for activated C-kinase (LACK) induces both interferon-gamma and interleukin-10 in natural killer cells of healthy blood donors.

Authors:  K Maasho; I Satti; S Nylén; G Guzman; F Koning; H Akuffo
Journal:  J Infect Dis       Date:  2000-07-24       Impact factor: 5.226

8.  Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis.

Authors:  P N Rocha; R P Almeida; O Bacellar; A R de Jesus; D C Filho; A C Filho; A Barral; R L Coffman; E M Carvalho
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

9.  A limiting dilution assay for quantifying Leishmania major in tissues of infected mice.

Authors:  R G Titus; M Marchand; T Boon; J A Louis
Journal:  Parasite Immunol       Date:  1985-09       Impact factor: 2.280

10.  Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method.

Authors:  J Field; J Nikawa; D Broek; B MacDonald; L Rodgers; I A Wilson; R A Lerner; M Wigler
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

View more
  14 in total

1.  Transforming growth factor beta 1 production by CD4+ CD25+ regulatory T cells in peripheral blood mononuclear cells from healthy subjects stimulated with Leishmania guyanensis.

Authors:  A Kariminia; E Bourreau; H Pascalis; P Couppié; D Sainte-Marie; F Tacchini-Cottier; P Launois
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Th1 cell development induced by cysteine proteinases A and B in localized cutaneous leishmaniasis due to Leishmania guyanensis.

Authors:  Hervé Pascalis; Anne Lavergne; Eliane Bourreau; Ghislaine Prévot-Linguet; Amina Kariminia; Roger Pradinaud; Sima Rafati; Pascal Launois
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  The skin homing receptor cutaneous leucocyte-associated antigen (CLA) is up-regulated by Leishmania antigens in T lymphocytes during active cutaneous leishmaniasis.

Authors:  C de O Mendes-Aguiar; A Gomes-Silva; E Nunes; R Pereira-Carvalho; R S Nogueira; M de P Oliveira-Neto; A L Bertho; A M Da-Cruz
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

4.  Proteomic approach for characterization of immunodominant membrane-associated 30- to 36-kiloDalton fraction antigens of Leishmania infantum promastigotes, reacting with sera from Mediterranean visceral leishmaniasis patients.

Authors:  Sayda Kamoun-Essghaier; Ikram Guizani; Jean Marc Strub; Alain Van Dorsselaer; Kamel Mabrouk; Lazhar Ouelhazi; Koussay Dellagi
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

5.  Antigen specific correlations of cellular immune responses in human leishmaniasis suggests mechanisms for immunoregulation.

Authors:  L R V Antonelli; W O Dutra; R P Almeida; O Bacellar; K J Gollob
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

6.  Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania.

Authors:  Blaise Dondji; Eszter Deak; Karen Goldsmith-Pestana; Eva Perez-Jimenez; Mariano Esteban; Sachiko Miyake; Takashi Yamamura; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2008-03       Impact factor: 5.532

7.  Apoptotic-like Leishmania exploit the host's autophagy machinery to reduce T-cell-mediated parasite elimination.

Authors:  Peter Crauwels; Rebecca Bohn; Meike Thomas; Stefan Gottwalt; Florian Jäckel; Susi Krämer; Elena Bank; Stefan Tenzer; Paul Walther; Max Bastian; Ger van Zandbergen
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

Review 8.  The Role of CD4 and CD8 T Cells in Human Cutaneous Leishmaniasis.

Authors:  Claire da Silva Santos; Cláudia Ida Brodskyn
Journal:  Front Public Health       Date:  2014-09-29

9.  Leishmania major LACK antigen is required for efficient vertebrate parasitization.

Authors:  Ben L Kelly; Daniel B Stetson; Richard M Locksley
Journal:  J Exp Med       Date:  2003-12-01       Impact factor: 14.307

10.  Profile of central and effector memory T cells in the progression of chronic human chagas disease.

Authors:  Jacqueline Araújo Fiuza; Ricardo Toshio Fujiwara; Juliana Assis Silva Gomes; Manoel Otávio das Costa Rocha; Ana Thereza Chaves; Fernanda Fortes de Araújo; Rafaelle Christine Gomes Fares; Andrea Teixeira-Carvalho; Olindo de Assis Martins-Filho; Guilherme Grossi Lopes Cançado; Rodrigo Correa-Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2009-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.